A new MiraLAX study was done as part of various efforts to resolve the continuing concerns of long-term PEG 3350 use in children. An October 4, 2018, Gastroenterology & Endoscopy News article, “New Study Tries to Address PEG 3350 Safety Concerns”, provides a comprehensive summary of the study.
Though this new MiraLAX study sought to ease the minds of worrying parents, thousands are displeased with the results and, in fact, are left seeking even more information than before.
We are aware that these inconclusive MiraLAX studies are creating a population of frustrated, information-seeking parents. That being said, our analysis of this possible drug-safety problem is ongoing and we remain open to any new or relevant information parents and medical researchers may have.[Read article in full at original source]